Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

JLL Releases 2014 Global Life Sciences Cluster Report; New Jersey-New York Ranked No. 5

San Diego, NJ, June 25, 2014 — Global shifts in the life sciences landscape may be rewriting the global map, but U.S. cities continue to lead the world in biopharmaceutical resources and enterprises.  Access to talent and research is keeping cities like Boston, San Francisco and San Diego and New Jersey-New York City at the top of the U.S. life sciences clusters list.

Factors shaping these clusters, and the city rankings, were revealed in JLL’s (NYSE: JLL) third annual Global Life Sciences Cluster Report released today at the BIO International Convention.

“The right-sizing and reshuffling of the global biopharmaceutical companies has left its mark on key U.S. cities,” said Roger Humphrey, Executive Managing Director of JLL’s Life Sciences group.  “The strongest U.S. clusters have retained their competitive advantages, and continue to thrive as top centers of talent and innovation.”

The 2014 JLL Global Life Sciences Cluster Report analyses top U.S. life sciences clusters, ranks the cities for their prominence in the industry and also offers an analysis of global trends in 17 countries.

According to the report, Greater Boston is the number one U.S. life sciences cluster followed by San Francisco/Bay Area, San Diego Metro, Raleigh-Durham., New Jersey/New York City/Westchester, Los Angeles/Orange County, Philadelphia, Suburban Maryland/Washington, DC Metro, Minneapolis/St. Paul and Seattle.

For the complete story, click here.

To view or download the 134-page JLL report, click here.